PROPANC BIOPHARMA, INC. Stock-Based Compensation
PROPANC BIOPHARMA, INC. (PPCB) reported Stock-Based Compensation of $7.27 million for the 9-month period ending 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.77M.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.47M.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.02M.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $3.12M.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $2.41K, a 96.68% decline from fiscal 2022.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $72.51K, a 12.50% decline from fiscal 2021.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $82.87K, a 72.41% decline from fiscal 2020.
- PROPANC BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $300.42K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 51 month | Share-based Payment Arrangement, Noncash Expense 54 month | Share-based Payment Arrangement, Noncash Expense 57 month | Share-based Payment Arrangement, Noncash Expense 60 month | Share-based Payment Arrangement, Noncash Expense 63 month | Share-based Payment Arrangement, Noncash Expense 66 month | Share-based Payment Arrangement, Noncash Expense 68 month | Share-based Payment Arrangement, Noncash Expense 72 month | Share-based Payment Arrangement, Noncash Expense 75 month | Share-based Payment Arrangement, Noncash Expense 77 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $1.77M derived: S-1 9 month − S-1 6 month · filed 2026-07-17 | $4.25M derived: sum of 2 quarters · filed 2026-07-17 | $7.27M S-1 · filed 2026-07-17 | $10.39M derived: sum of 4 quarters · filed 2026-07-17 | ||||||||||
| 2025-12-31 | $2.47M derived: S-1 6 month − 10-Q 3 month · filed 2026-04-10 | $5.50M S-1 · filed 2026-04-10 | $8.61M derived: sum of 3 quarters · filed 2026-07-17 | |||||||||||
| 2025-09-30 | $3.02M 10-Q · filed 2025-11-14 | $6.14M derived: sum of 2 quarters · filed 2026-07-17 | ||||||||||||
| 2025-06-30 | $3.12M derived: S-1 12 month − S-1 9 month · filed 2026-07-17 | $4.62M S-1 · filed 2026-07-17 | ||||||||||||
| 2025-03-31 | $1.51M S-1 · filed 2026-07-17 | |||||||||||||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $0.00 derived: sum of 3 quarters · filed 2024-09-30 | $2.41K 10-K · filed 2024-09-30 | ||||||||||
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-05-15 | $2.41K 10-Q · filed 2024-05-15 | $12.77K derived: sum of 4 quarters · filed 2024-05-15 | ||||||||||
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-20 | $2.41K 10-Q · filed 2024-02-20 | $12.77K derived: sum of 3 quarters · filed 2024-02-20 | $33.48K derived: sum of 4 quarters · filed 2024-02-20 | ||||||||||
| 2022-09-30 | $2.41K 10-Q · filed 2023-11-14 | $12.77K derived: sum of 2 quarters · filed 2023-11-14 | $33.48K derived: sum of 3 quarters · filed 2023-11-14 | $54.20K derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||
| 2022-06-30 | $10.36K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $31.08K derived: sum of 2 quarters · filed 2023-09-28 | $51.80K derived: sum of 3 quarters · filed 2023-09-28 | $72.51K 10-K · filed 2023-09-28 | ||||||||||
| 2022-03-31 | $20.72K 10-Q · filed 2022-05-16 | $41.44K derived: sum of 2 quarters · filed 2022-05-16 | $62.15K 10-Q · filed 2023-05-15 | $82.87K derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-12-31 | $20.72K 10-Q · filed 2022-02-14 | $41.44K 10-Q · filed 2023-02-10 | $62.15K derived: sum of 3 quarters · filed 2022-11-14 | $82.87K derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-09-30 | $20.72K 10-Q · filed 2022-11-14 | $41.44K derived: sum of 2 quarters · filed 2022-11-14 | $62.15K derived: sum of 3 quarters · filed 2022-11-14 | $82.87K derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||
| 2021-06-30 | $20.72K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | $41.44K derived: sum of 2 quarters · filed 2022-09-28 | $62.15K derived: sum of 3 quarters · filed 2022-09-28 | $82.87K 10-K · filed 2022-09-28 | ||||||||||
| 2021-03-31 | $20.72K 10-Q · filed 2022-05-16 | $41.44K derived: sum of 2 quarters · filed 2022-05-16 | $62.15K 10-Q · filed 2022-05-16 | $137.26K derived: sum of 4 quarters · filed 2022-05-16 | ||||||||||
| 2020-12-31 | $20.72K 10-Q · filed 2022-02-14 | $41.44K 10-Q · filed 2022-02-14 | $116.54K derived: sum of 3 quarters · filed 2022-02-14 | $137.26K derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||
| 2020-09-30 | $20.72K 10-Q · filed 2021-11-12 | $95.82K derived: sum of 2 quarters · filed 2021-11-12 | $116.54K derived: sum of 3 quarters · filed 2021-11-12 | $137.26K derived: sum of 4 quarters · filed 2021-11-12 | ||||||||||
| 2020-06-30 | $75.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $95.82K derived: sum of 2 quarters · filed 2021-09-28 | $116.54K derived: sum of 3 quarters · filed 2021-09-28 | $300.42K 10-K · filed 2021-09-28 | ||||||||||
| 2020-03-31 | $20.72K 10-Q · filed 2021-05-14 | $41.44K derived: sum of 2 quarters · filed 2021-05-14 | $225.31K 10-Q · filed 2021-05-14 | |||||||||||
| 2019-12-31 | $20.72K 10-Q · filed 2021-02-12 | $150.21K 10-Q · filed 2021-02-12 | ||||||||||||
| 2019-09-30 | $114.90K 10-Q · filed 2020-11-16 | |||||||||||||
| 2018-06-30 | $25.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-17 | $186.39K derived: sum of 2 quarters · filed 2018-09-17 | $351.27K derived: sum of 3 quarters · filed 2018-09-17 | $516.15K 10-K · filed 2018-09-17 | ||||||||||
| 2018-03-31 | $161.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-10 | $326.18K derived: sum of 2 quarters · filed 2018-05-10 | $491.06K 10-Q · filed 2018-05-10 | |||||||||||
| 2017-12-31 | $164.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-09 | $329.76K 10-Q · filed 2018-02-09 | ||||||||||||
| 2017-09-30 | $164.88K 10-Q · filed 2017-11-09 | |||||||||||||
| 2017-06-30 | $1.69M 10-K · filed 2018-09-17 | |||||||||||||
| 2016-06-30 | $1.72M 10-K · filed 2017-09-28 | |||||||||||||
| 2014-03-31 | $299.74K 10-Q · filed 2014-05-20 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-Q 75 month − 10-Q 72 month · filed 2014-02-14 | $299.74K 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | $299.74K 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | $299.74K 10-K · filed 2013-10-15 | |||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 66 month − 10-Q 63 month · filed 2013-05-20 | $0.00 derived: sum of 2 quarters · filed 2013-05-20 | $0.00 derived: sum of 3 quarters · filed 2013-05-20 | $0.00 derived: sum of 4 quarters · filed 2013-05-20 | $299.74K 10-Q · filed 2013-05-20 | |||||||||
| 2012-12-31 | $0.00 derived: 10-Q 63 month − 10-Q 60 month · filed 2013-02-20 | $0.00 derived: sum of 2 quarters · filed 2013-02-20 | $0.00 derived: sum of 3 quarters · filed 2013-02-20 | $0.00 derived: sum of 4 quarters · filed 2013-02-20 | $299.74K 10-Q · filed 2013-02-20 | |||||||||
| 2012-09-30 | $0.00 derived: 10-Q 60 month − 10-K 57 month · filed 2012-11-19 | $0.00 derived: sum of 2 quarters · filed 2012-11-19 | $0.00 derived: sum of 3 quarters · filed 2012-11-19 | $299.74K 10-Q · filed 2012-11-19 | ||||||||||
| 2012-06-30 | $0.00 derived: 10-K 57 month − 10-Q 54 month · filed 2012-10-15 | $0.00 derived: sum of 2 quarters · filed 2012-10-15 | $299.74K 10-K · filed 2012-10-15 | |||||||||||
| 2012-03-31 | $0.00 derived: 10-Q 54 month − 10-Q/A 51 month · filed 2012-05-21 | $299.74K 10-Q · filed 2012-05-21 | ||||||||||||
| 2011-12-31 | $0.00 10-Q/A · filed 2012-03-07 | $299.74K 10-Q/A · filed 2012-03-07 | ||||||||||||
| 2010-12-31 | $0.00 10-Q/A · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |